These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15318164)

  • 1. Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF.
    Sedegah M; Charoenvit Y; Aguiar J; Sacci J; Hedstrom R; Kumar S; Belmonte A; Lanar DE; Jones TR; Abot E; Druilhe P; Corradin G; Epstein JE; Richie TL; Carucci DJ; Hoffman SL
    Genes Immun; 2004 Nov; 5(7):553-61. PubMed ID: 15318164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.
    Wang R; Richie TL; Baraceros MF; Rahardjo N; Gay T; Banania JG; Charoenvit Y; Epstein JE; Luke T; Freilich DA; Norman J; Hoffman SL
    Infect Immun; 2005 May; 73(5):2863-72. PubMed ID: 15845492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine.
    Weiss WR; Ishii KJ; Hedstrom RC; Sedegah M; Ichino M; Barnhart K; Klinman DM; Hoffman SL
    J Immunol; 1998 Sep; 161(5):2325-32. PubMed ID: 9725227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.
    Okada E; Sasaki S; Ishii N; Aoki I; Yasuda T; Nishioka K; Fukushima J; Miyazaki J; Wahren B; Okuda K
    J Immunol; 1997 Oct; 159(7):3638-47. PubMed ID: 9317164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced immunogenicity of DNA vaccine plasmids in mixtures.
    Sedegah M; Charoenvit Y; Minh L; Belmonte M; Majam VF; Abot S; Ganeshan H; Kumar S; Bacon DJ; Stowers A; Narum DL; Carucci DJ; Rogers WO
    Gene Ther; 2004 Mar; 11(5):448-56. PubMed ID: 14973538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaxfectin enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses.
    Sedegah M; Rogers WO; Belmonte M; Belmonte A; Banania G; Patterson NB; Rusalov D; Ferrari M; Richie TL; Doolan DL
    Vaccine; 2010 Apr; 28(17):3055-65. PubMed ID: 19879998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF.
    Zhai YZ; Li XM; Zhou Y; Ma L; Feng GH
    Intervirology; 2009; 52(3):152-63. PubMed ID: 19521104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.
    Mévélec MN; Bout D; Desolme B; Marchand H; Magné R; Bruneel O; Buzoni-Gatel D
    Vaccine; 2005 Aug; 23(36):4489-99. PubMed ID: 15935521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection.
    Ismael AB; Hedhli D; Cérède O; Lebrun M; Dimier-Poisson I; Mévélec MN
    Vaccine; 2009 May; 27(22):2959-66. PubMed ID: 19428907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modulation of immune response to Plasmodium falciparum apical membrane antigen 1 DNA vaccine by cytokine plasmids].
    Li X; Miao J; Lei JC; Xue CF; Wang XF; Liu ZX; Li SM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Jun; 22(3):136-8. PubMed ID: 15597706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.
    Sedegah M; Weiss W; Sacci JB; Charoenvit Y; Hedstrom R; Gowda K; Majam VF; Tine J; Kumar S; Hobart P; Hoffman SL
    J Immunol; 2000 Jun; 164(11):5905-12. PubMed ID: 10820272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined DNA vaccination against three animal viruses elicits decreased immunogenicity of a single plasmid in mice.
    Wang KY; Guo YJ; Zhang YL; Lv K; Sun SH
    Vaccine; 2007 May; 25(22):4429-36. PubMed ID: 17420075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of immune responses elicited by recombinant protein and eukaryotic expression plasmid based on histidine rich protein 2 of Plasmodium falciparum].
    Li X; Miao J; Xue CF; Zhen RF; Liu ZX; Wang XF; Mu SJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(1):7-10. PubMed ID: 12572014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF).
    Lima J; Jenkins C; Guerrero A; Triozzi PL; Shaw DR; Strong TV
    Vaccine; 2005 Jan; 23(10):1273-83. PubMed ID: 15652670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.
    Richie TL; Charoenvit Y; Wang R; Epstein JE; Hedstrom RC; Kumar S; Luke TC; Freilich DA; Aguiar JC; Sacci JB; Sedegah M; Nosek RA; De La Vega P; Berzins MP; Majam VF; Abot EN; Ganeshan H; Richie NO; Banania JG; Baraceros MF; Geter TG; Mere R; Bebris L; Limbach K; Hickey BW; Lanar DE; Ng J; Shi M; Hobart PM; Norman JA; Soisson LA; Hollingdale MR; Rogers WO; Doolan DL; Hoffman SL
    Hum Vaccin Immunother; 2012 Nov; 8(11):1564-84. PubMed ID: 23151451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.
    Zhang X; Divangahi M; Ngai P; Santosuosso M; Millar J; Zganiacz A; Wang J; Bramson J; Xing Z
    Vaccine; 2007 Jan; 25(7):1342-52. PubMed ID: 17052817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific immune responses in Balb/c mice induced by plasmid coexpressing hepatitis B surface antigen and granulocyte-macrophage colony stimulating factor].
    Qing YL; Ling N; Zhao JJ; Peng ML; Xu HM; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):474-6. PubMed ID: 12939179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coadministration of chicken GM-CSF with a DNA vaccine expressing infectious bronchitis virus (IBV) S1 glycoprotein enhances the specific immune response and protects against IBV infection.
    Tan B; Wang H; Shang L; Yang T
    Arch Virol; 2009; 154(7):1117-24. PubMed ID: 19543689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.